Log in

A case-control study on risk factors for scleroderma

  • Original Article
  • Published:
Japanese Journal of Rheumatology

Abstract

We conducted a case-control study to evaluate the contribution of some risk factors to the development of scleroderma. Fifty-seven patients with scleroderma (seven males and 50 females) were interviewed with a structured questionnaire at Saga Medical School Hospital from 1993 to 1995. Fifty-seven controls, who were individually sex and age matched with each case, were also interviewed with the same questionnaire during the same period. Eight individuals of parents or siblings of the scleroderma patients had Raynaud’s phenomenon, as compared to none of the controls (P<0.01). Four siblings of the cases had been affected by autoimmune connective tissue diseases, as compared to none of the controls (P<0.05). The percentage of the cases who had experience in the work exposed to hand-arm stress or vibration was larger than that of the controls (P<0.05). These findings may reflect familial or environmental factors operating in the development of scleroderma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Masi AT, Clinical-epidemiological perspective of systemic sclerosis (scleroderma), in:Systemic Sclerosis: Scleroderma, Jayson MIV, Black CM (Eds), pp. 7–31. Wiley, New York (1988).

    Google Scholar 

  2. Steen VD, Oddis CV, Conte CGet al., Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982,Arthritis Rheum 40, 441–445 (1997).

    Article  PubMed  CAS  Google Scholar 

  3. Tamaki T, Mori S, Takehara K, Epidemiological study of patients with systemic sclerosis in Tokyo,Arch Dermatol Res 283, 366–371 (1991).

    Article  PubMed  CAS  Google Scholar 

  4. Michet CJ Jr, McKenna CH, Elveback LRet al., Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979,Mayo Clin Proc 60, 105–113 (1985).

    PubMed  Google Scholar 

  5. Maricq HR, Weinrich MC, Keil JEet al., Prevalence of scleroderma spectrum disorders in the general population of South Carolina,Arthritis Rheum 32, 998–1006 (1989).

    Article  PubMed  CAS  Google Scholar 

  6. Silman AJ, Epidemiology of scleroderma,Ann Rheum Dis 50, 846–853 (1991).

    Article  PubMed  Google Scholar 

  7. Welsh KI, Black CM, Environmental and genetic factors in Scleroderma, in:Systemic Sclerosis: Scleroderma, Jayson MIV, Black CM (Eds), pp. 33–47. Wiley, New York (1988).

    Google Scholar 

  8. Silman AJ, Hochberg MC, in:Epidemiology of the Rheumatic Diseases, pp. 193–216. Oxford University Press, Oxford (1993).

    Google Scholar 

  9. Schlesselman JJ, in:Case-control Studies. Design, Conduct, Analysis, pp. 7–123. Oxford University Press, Oxford (1982).

    Google Scholar 

  10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Preliminary criteria for the classification of systemic sclerosis (scleroderma),Arthritis Rheum 23, 581–590 (1980).

    Article  Google Scholar 

  11. Breslow NE, Day NE, in:Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-control Studies, pp. 247–279. IARC, Lyon (1980).

    Google Scholar 

  12. SAS Institute Inc, SAS Technical Report P-217, SAS/STAT Software, The PHREG Procedure, Version 6, pp. 1–59. SAS Institute, Cary (1991).

    Google Scholar 

  13. Sheldon WB, Lurie DP, Maricq HRet al., Three siblings with scleroderma (systemic sclerosis) and two with Raynaud’s phenomenon from a single kindred,Arthritis Rheum 24, 668–676 (1981).

    Article  PubMed  CAS  Google Scholar 

  14. McGregor AR, Watson A, Yunis Eet al., Familial clustering of scleroderma spectrum disease,Am J Med 84, 1023–1032 (1988).

    Article  PubMed  CAS  Google Scholar 

  15. Bunker CB, Atherton D, Gray OPet al., Familial Raynaud’s phenomenon and localized scleroderma associated with essential telangiectasia and cytogenetic abnormalities,J Royal Soc Med 83, 531–532 (1990).

    CAS  Google Scholar 

  16. Maddison PJ, Stephens C, Briggs Det al., Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis,Medicine 72, 103–112 (1993).

    Article  PubMed  CAS  Google Scholar 

  17. Flores RH, Stevens MB, Arnett FC, Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus,J Rheumatol 11, 321–323 (1984).

    PubMed  CAS  Google Scholar 

  18. Rose T, Nothjunge J, Schlote W, Familial occurrence of dermatomyositis and progressive scleroderma after injection of a local anesthetic for dental treatment,Eur J Pediatr 143, 225–228 (1985).

    Article  PubMed  CAS  Google Scholar 

  19. Stephens CO, Briggs DC, Whyte Jet al., Familial scleroderma-evidence for environmental versus genetic trigger,Br J Rheumatol 33, 1131–1135 (1994).

    Article  PubMed  CAS  Google Scholar 

  20. Manolios N, Dunckley H, Chivers Tet al., Immunogenetic analysis of 5 families with multicast occurrence of scleroderma and/or related variants,J Rheumatol 22, 85–92 (1995).

    PubMed  CAS  Google Scholar 

  21. Maeda M, Mori S, Occupational or extrinsic stimulation factors and initial signs of progressive systemic sclerosis,Int J Dermatol 31, 257–259 (1992).

    Article  PubMed  CAS  Google Scholar 

  22. Maeda M, Matsubara Ket al., Pitting scar in progressive systemic sclerosis,Dermatology 187, 104–108 (1993).

    Article  PubMed  CAS  Google Scholar 

  23. Pelmear PL, Roos JO, Maehle WM, Occupationally-induced scleroderma,J Occup Med 34, 20–25 (1992).

    PubMed  CAS  Google Scholar 

  24. Sluis-Cremer GK, Hessel PA, Nizdo EHet al., Silica, silicosis, and progressive systemic sclerosis,Br J Ind Med 42, 838–843 (1985).

    PubMed  CAS  Google Scholar 

  25. Rustin MHA, Bull HA, Ziegler Vet al., Silica-associated systemicc sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis,Br J Dermatol 123, 725–734 (1990).

    Article  PubMed  CAS  Google Scholar 

  26. Sanchez-Roman J, Wichmann I, Salaberri Jet al., Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica,Ann Rheum Dis 52, 534–538 (1993).

    Article  PubMed  CAS  Google Scholar 

  27. Black CM, Welsh KI, Walker AEet al., Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride,Lancet i, 53–55 (1983).

    Article  Google Scholar 

  28. Silman AJ, Jones S, What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?Ann Rheum Dis 51, 1322–1324 (1992).

    Article  PubMed  CAS  Google Scholar 

  29. Giordano M, Valentini G, Lupoli S, Giordano A, Pregnancy and systemic sclerosis,Arthritis Rheum 33, 237–238 (1985).

    Article  Google Scholar 

  30. Silman AJ, Black CM, Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study,Ann Rheum Dis 47, 441–444 (1988).

    Article  PubMed  CAS  Google Scholar 

  31. McHugh NJ, Reilly PA, McHugh LA, Pregnancy outcome and antibodies in connective tissue disease,J Rheumatol 16, 42–46 (1989).

    PubMed  CAS  Google Scholar 

  32. Steen VD, Conte C, Day Net al., Pregnancy in women with systemic sclerosis,Arthritis Rheum 32, 151–157 (1989).

    Article  PubMed  CAS  Google Scholar 

  33. Englert H, Brennan P, McNeil Det al., Reproductive function prior to disease onset in women with scleroderma,J Rheumatol 19, 1575–1579 (1992).

    PubMed  CAS  Google Scholar 

  34. Research Committee on Epidemiology of Intractable Diseases, in:Tokutei Shikkan Iryo Jyukyusha Chosashiryo, p. 137. The Ministry of Health and Welfare of Japan, Tokyo (1990) (in Japanese).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Mori, M., Ohta, A., Suzuki, N. et al. A case-control study on risk factors for scleroderma. Japanese Journal of Rheumatology 8, 239–248 (1998). https://doi.org/10.1007/BF03041245

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03041245

Key words

Navigation